| Literature DB >> 17408953 |
Joël Robichaud1, Christopher I Bayly, W Cameron Black, Sylvie Desmarais, Serge Léger, Frédéric Massé, Daniel J McKay, Renata M Oballa, Julie Pâquet, M David Percival, Jean-François Truchon, Gregg Wesolowski, Sheldon N Crane.
Abstract
Further SAR study around the central 1,2-disubstituted phenyl of the previously disclosed Cat K inhibitor (-)-1 has demonstrated that the solvent exposed P2-P3 linker can be replaced by various 5- or 6-membered heteroaromatic rings. While some potency loss was observed in the 6-membered heteroaromatic series (IC(50)=1 nM for pyridine-linked 4 vs 0.5 nM for phenyl-linked (+/-)-1), several inhibitors showed a significantly decreased shift in the bone resorption functional assay (10-fold for pyridine 4 vs 53-fold for (-)-1). Though this shift was not reduced in the 5-membered heteroaromatic series, potency against Cat K was significantly improved for thiazole 9 (IC(50)=0.2 nM) as was the pharmacokinetic profile of N-methyl pyrazole 10 over our lead compound (-)-1.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17408953 DOI: 10.1016/j.bmcl.2007.03.028
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823